Keyphrases
3 Fatty Acids
36%
Adipose Tissue
31%
Antiplatelet Therapy
31%
Aortic Aneurysm Repair
31%
Aortic Dissection
22%
Aspirin
12%
Atherosclerotic Cardiovascular Disease (ASCVD)
63%
Atherosclerotic CVD
21%
B Cell Differentiation
10%
B Cell Subpopulations
31%
B Cell Subsets
21%
B Cells
21%
Biological Classification
21%
Cardiovascular Burden
15%
Cardiovascular Consequences
15%
Carotid Artery Stenosis
11%
Carotid Endarterectomy
31%
Case-cohort Study
31%
Cause of Death
22%
Cell-like
10%
Cellular Hierarchy
31%
Centroblasts
10%
Centrocyte
10%
Chronic Obstructive Pulmonary Disease
13%
Claudication
12%
Clinical Characteristics
31%
Clopidogrel
12%
Comorbidity
13%
Cost-effectiveness Evaluation
31%
Critical Ischemia
18%
Critical Limb Ischemia
11%
Cumulative Incidence
12%
Cyclin D
10%
Danish Case
31%
Danish National Patient Registry
12%
Danish Population
63%
Diabetes
63%
Direct Strategy
10%
Docosahexaenoic Acid
47%
Eicosapentaenoic Acid
47%
Endovascular Abdominal Aortic Aneurysm Repair
31%
Endovascular Aneurysm Repair
31%
Femoral Artery
15%
Femoro-femoral
15%
Femoro-femoral Bypass
31%
First Year
12%
Geographic Disparities
31%
Germinal Center B
10%
Global Gene Expression Profiling
10%
Hazard Ratio
18%
Heparin Coated
31%
Hypertension
13%
Incidence Rate
38%
Infected Aortic Aneurysm
18%
Infrainguinal Bypass
15%
Inverse Association
11%
Ischemic Events
21%
Low Risk
51%
Lower Extremity Arterial Disease
31%
Lower Limb Amputation
63%
Lymph Node
10%
Lymphoid Tissue
10%
Lymphoma Subtype
10%
Marfan Syndrome
31%
Marine Compounds
31%
Marine n-3 PUFA
31%
Memory B Cells
10%
Microarray Gene Expression
31%
Mortality Rate
34%
Multiparameter Flow Cytometry
10%
N-3 Polyunsaturated Fatty Acids
84%
National Cohort Study
10%
New User
25%
Non-traumatic
13%
Normal B Cells
31%
Open Aortic Aneurysm Repair
31%
Patients with Diabetes
40%
Peripheral Arterial Disease
100%
Peripheral Vascular Surgery
31%
Plant-derived
42%
Plasma Cells
10%
Plasmablast
10%
Population-based Cohort Study
63%
Poultry Meat
31%
Primary Patency
11%
Proportion of Days Covered
12%
PTFE Graft
15%
Remote Ischemic Preconditioning
31%
Risk Factors
13%
RNA Amplification
31%
Sex-related
31%
Systematic Strategies
10%
Thymus
10%
Tissue Content
31%
Type A Aortic Dissection
31%
Type B Aortic Dissection
37%
Vascular Procedures
31%
Vascular Surgery
36%
Without Diabetes
26%
α-linolenic Acid
72%
Medicine and Dentistry
Abdominal Aorta
21%
Abdominal Aortic Aneurysm
94%
Abdominal Aortic Aneurysm Repair
15%
Acetylcholine
7%
All Cause Mortality
6%
Amputation
40%
Aneurysm
10%
Antithrombotic
15%
Aortic Aneurysm
58%
Aortic Dissection
63%
Aortic Root
10%
Aortic Root Surgery
10%
Aortic Surgery
10%
Apoplexy
48%
Arteriosclerosis Obliterans
84%
Artery
31%
Atherosclerosis
31%
B Cell
34%
B Lymphocyte Subpopulation
15%
Beinaglutide
7%
Bypass Surgery
34%
Cancer
31%
Cardiovascular Disease
26%
Cardiovascular Mortality
31%
Cardiovascular System
28%
Carotid Artery Stenosis
11%
Carotid Endarterectomy
31%
Chronic Obstructive Pulmonary Disease
11%
Claudication
10%
Clinical Trial
5%
Cohort Analysis
71%
Combination Therapy
53%
Cost-Effectiveness Analysis
31%
Critical Limb Ischemia
7%
Diabetes
78%
Diagnosis
18%
Dietary Intake
7%
Diffuse Large B-Cell Lymphoma
35%
Endarterectomy
21%
Endovascular Aneurysm Repair
31%
Epileptic Absence
10%
Exendin 9
10%
Exon
5%
Femoral Artery
10%
Femoropopliteal Bypass
36%
Gene Expression Profiling
6%
Glucagon Like Peptide 1
31%
Glucagon Like Peptide 1 Receptor
10%
Hazard Ratio
37%
Health Care Cost
31%
Heart Surgery
34%
Hemorrhagic Shock
10%
Heparin
63%
ICD-10
8%
Infection
20%
Intention-to-Treat Analysis
5%
Ischemia
15%
Ischemic Preconditioning
31%
Kaplan Meier Method
5%
Leg Amputation
63%
Linolenic Acid
63%
Long Term Survival
12%
Long-Term Care
5%
Marfan Syndrome
31%
Medical Record
8%
Memory B Cell
35%
middle age
11%
Mortality Rate
34%
Myocardial Infarction
57%
Negative Pressure Wound Therapy
31%
Open Surgery
31%
Patient Experience
31%
Patient Participation
15%
Patient Registry
35%
Patient-Data
15%
Politef
36%
Postoperative Infection
6%
Prescription Medication
5%
Primary Mediastinal B-Cell Lymphoma
12%
Prophylaxis
10%
Quality Adjusted Life Year
26%
Quality Improvement
15%
Randomized Clinical Trial
31%
Randomized Controlled Trial
31%
Recurrent Disease
31%
Rehabilitation Engineering
5%
Renal Failure
15%
Revascularization
5%
Sepsis
6%
Short Term Survival
6%
Statin
18%
Surgeon
31%
Surgery
47%
Surgical Infection
31%
Survival Estimate
6%
Transient Ischemic Attack
5%
Vascular Surgery
95%
Vasodilatation
31%
Wound Complication
15%
Wound Healing
15%